Scholars@Duke publication: Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy

Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy

Publication , Conference

Smith, T; Hull, JA; Fusco, RM; Blondel, L; Elmore, Z; Asokan, A

Published in: MOLECULAR THERAPY

2023

MOLECULAR THERAPY

1525-0024

1525-0016

2023

113 / 113

APA

Chicago

ICMJE

MLA

NLM

Smith, T., Hull, J. A., Fusco, R. M., Blondel, L., Elmore, Z., & Asokan, A. (2023). Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy. In MOLECULAR THERAPY (Vol. 31, pp. 113–113).

Smith, Timothy, Joshua A. Hull, Robert M. Fusco, Leo Blondel, Zachary Elmore, and Aravind Asokan. “Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy.” In MOLECULAR THERAPY, 31:113–113, 2023.

Smith T, Hull JA, Fusco RM, Blondel L, Elmore Z, Asokan A. Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy. In: MOLECULAR THERAPY. 2023. p. 113–113.

Smith, Timothy, et al. “Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy.” MOLECULAR THERAPY, vol. 31, no. 4, 2023, pp. 113–113.

Smith T, Hull JA, Fusco RM, Blondel L, Elmore Z, Asokan A. Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy. MOLECULAR THERAPY. 2023. p. 113–113.

MOLECULAR THERAPY

1525-0024

1525-0016

2023

113 / 113